The National Inquiry into Management and Medicine looked at hospitals across the UK, focussing on the often troubled relationships between doctors and NHS managers. It found that where the two sides have formed a genuine alliance, the health service runs more efficiently ? and patient outcomes are improved.
Using novel light-scattering techniques, researchers have found the first evidence that early stage pancreatic cancer causes subtle changes in part of the small intestine.
Geisinger Health System was recently named a 2007 Computerworld Honors Laureate, an honor that recognizes Geisinger?s innovations in using information technology in healthcare. The award was accepted on behalf of Geisinger by chief innovation and technology officer, Ronald A. Paulus, MD.
Synova Healthcare Group, Inc. announced that the Today(r) Sponge, the first and only female contraceptive to combine a spermicide with a barrier contraceptive, is unveiling its exciting new look this summer.
What people have come to expect in cell phones and personal communicators may soon become common in health-care devices and products at home and in medical offices, thanks to new technology announced today by the University of Florida and IBM.
Toronto Public Health is investigating an outbreak of E.coli 0157 among individuals who attended a picnic in Scarborough’s Morningside Park on July 1. Several hundred people attended the event, which was a reunion for the Punqudutivu Students Association of Sri Lanka.
A Penn State researcher argues that ambiguous international rules outlining when and how governments may “break” pharmaceutical patents may end up significantly reducing incentives for innovation while at the same time failing to increase access to medicines.
Scientists will only make real breakthroughs in children?s medicine if they include children in research programmes as well as adults, according to a leading paediatric expert.
Scientists have discovered a new type of mouse embryonic stem cell that is the closest counterpart yet to human embryonic stem cells, the National Institutes of Health announced today. The cells are expected to serve as an improved model for human ES cells in studies of regeneration, disease pathology and basic stem cell biology.
With nearly $1 million in government funding, University of Rochester scientists are testing a new innovation in biotherapy by altering a common childhood respiratory virus, the adenovirus, to destroy cancer cells.